ArticleThoracic cancer2023

COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy.

Jian-Hua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.